Enorama Pharma AB OMXSTO:ERMA:
Q1 NET SALES AMOUNTED TO -109 KSEK
Q1 OPERATING RESULT AMOUNTED TO -10,877 KSEK
Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln
Earlier from Enorama Pharma
- Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)
- Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million
- Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share Capital
- Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
- Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting
Later from Enorama Pharma
All Enorama Pharma news releasesFollow Enorama Pharma into a list and get an email when it puts out news.
Follow Enorama Pharma